Vacci-nation: A case study in health and prosperity

Article

Vaccines have been integral to health and prosperity in the last three centuries.

The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.

Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.

On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.

Related items

  1. The great enabler: transport’s role in tackling environmental crises and delivering progressive change

    In this special issue of IPPR Progressive Review we bring together leading political, academic and civil society thinkers to consider transport in modern Britain and its role in delivering a healthier, greener, more prosperous and…

  2. The shape of devolution

    How do we create transparent, fair and practical footprints for local power across England?
  3. Wind turbines near the Scottish borders on a sunny day

    Everything everywhere, all at once: The need for a four nations approach to accelerate wind deployment in the UK

    The UK is a world leader in wind deployment and has some of the most ambitious future wind capacity targets in the world, aiming for clean power by 2030.